Search results
Amneal has primary operations in Ahmedabad, where it produces oral solid dosage and injectables products. It also has facilities in Hyderabad, Dahej, Rajoda and Vizag for API and oncology products.
- Responsibility
Responsibility. We are guided by a deep sense of purpose: We...
- India Leadership
Amneal leaders share an enduring passion for quality,...
- About Us
Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) is a U.S.-based...
- News
March 10, 2023 Amneal strengthens commitment in India as...
- Critical Care
Amneal’s innovative and growing portfolio of critical care...
- Total Rewards
Our India-based team members play an essential role in...
- Responsibility
901-911, 9th Floor, ISCON ELEGANCE, Near Hotel Crowne Plaza, S. G. Highway, Ahmedabad – 380015, Gujarat, India.
Amneal operates from facilities in India and the U.S., including a new injectables plant in Ahmedabad, India. Learn more about Amneal's global presence, R&D, manufacturing and packaging capabilities.
The Amneal Patient Assistance Program. Product Donations. National and Local Philanthropy. Compliance and Ethics. Patient Community Connections. Our Commitment to Parkinson’s. Awards & Recognition. Products. ProductsWe create essential medicines.
Since 2008, we’ve been producing medicines for the U.S. market – a global leader and the gold standard in pharmaceutical quality. Today we’re bringing that same Amneal quality commitment to India patients and families.
Nov 9, 2021 · US-based pharma company Amneal Pharmaceuticals Inc buys Puniska Healthcare, an Ahmedabad-based injectibles company, for $93 million. The deal will enhance Amneal’s injectibles manufacturing capabilities in India and the US market.
People also ask
Who are Amneal Pharmaceuticals?
Is Amneal Pharmaceuticals acquiring puniska Healthcare Pvt Ltd?
Where is Amneal Pharmaceuticals Co India Pvt Ltd?
What is Amneal doing in India?
Nov 16, 2021 · Amneal Pharmaceuticals, the New Jersey-based drug maker promoted by NRI entrepreneur brothers Chirag Patel and Chintu Patel, will be making foray into India's domestic formulation market with focus on biologics, complex injectables and specialty drugs.